VolitionRx Limited Cash and Cash Equivalents
VolitionRx Limited (VNRX) had Cash and Cash Equivalents of $2.80 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.80M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $1.12M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $200.00K.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $2.30M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $2.80M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $1.12M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.30M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.60M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.26M 10-K · filed 2026-03-31 | |
| 2024-03-31 | $11.77M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $20.73M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $10.81M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $19.74M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $10.01M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $10.87M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $16.42M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $16.73M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $23.73M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $20.58M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $22.90M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $27.91M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $33.06M 10-Q · filed 2022-05-11 | |
| 2020-12-31 | $19.44M 10-Q · filed 2022-05-11 | |
| 2020-09-30 | $20.93M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $21.31M 10-Q · filed 2021-08-11 | |
| 2020-03-31 | $11.97M 10-Q · filed 2021-05-11 | |
| 2019-12-31 | $16.97M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $19.70M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $18.51M 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $16.17M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $13.43M 10-K · filed 2021-03-22 | |
| 2018-09-30 | $16.37M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $11.89M 10-Q · filed 2019-08-12 | |
| 2018-03-31 | $14.26M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $10.12M 10-Q · filed 2019-11-12 | |
| 2017-09-30 | $13.84M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $16.51M 10-Q · filed 2018-08-13 | |
| 2017-03-31 | $18.47M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $21.68M 10-K · filed 2019-03-13 | |
| 2016-09-30 | $12.53M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $14.50M 10-Q · filed 2017-08-10 | |
| 2016-03-31 | $17.01M 10-Q · filed 2017-05-11 | |
| 2015-12-31 | $5.92M 10-K · filed 2018-03-01 | |
| 2015-09-30 | $6.85M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $9.31M 10-Q · filed 2016-08-11 | |
| 2015-03-31 | $11.03M 10-Q · filed 2016-05-13 | |
| 2014-12-31 | $2.14M 10-K · filed 2017-03-10 | |
| 2014-09-30 | $2.42M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.81M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $2.80M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $888.70K 10-Q · filed 2014-11-06 | $888.80K 10-Q · filed 2014-05-15 |
| 2013-09-30 | $473.48K 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $750.75K 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $410.87K 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $376.42K 10-Q · filed 2013-10-31 | |
| 2012-09-30 | $315.28K 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $386.25K 10-Q · filed 2013-07-29 | |
| 2012-03-31 | $217.81K 10-Q · filed 2013-05-06 | |
| 2011-12-31 | $347.89K 10-Q · filed 2013-10-31 | |
| 2011-09-30 | $959.09K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $272.39K 10-Q · filed 2012-08-14 | |
| 2011-03-31 | $565.13K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $47.48K 10-K · filed 2013-04-01 | |
| 2010-08-04 | $0.00 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |